Detalhe da pesquisa
1.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
N Engl J Med
; 380(7): 617-628, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30516102
2.
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial.
Lancet Oncol
; 18(6): 755-769, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28479233
3.
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.
Breast Cancer Res
; 18(1): 67, 2016 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27349747
4.
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
Lancet Oncol
; 16(1): 25-35, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25524798
5.
Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.
Breast Cancer Res
; 16(4): R79, 2014 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25011585
6.
Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland.
Curr Oncol
; 31(3): 1302-1310, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534931
7.
A careful reassessment of anthracycline use in curable breast cancer.
NPJ Breast Cancer
; 7(1): 134, 2021 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625570
8.
NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab.
NPJ Breast Cancer
; 7(1): 55, 2021 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016989
9.
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.
Breast Cancer Res Treat
; 119(1): 145-53, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19731015
10.
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.
J Clin Oncol
; 38(5): 444-453, 2020 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821109
11.
BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer.
Clin Cancer Res
; 25(23): 7139-7150, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409615
12.
Pooled analysis of diarrhea events in patients with cancer treated with lapatinib.
Breast Cancer Res Treat
; 112(2): 317-25, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18204897
13.
p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.
Int J Oncol
; 52(2): 424-432, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29207087
14.
High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
Melanoma Res
; 25(3): 189-99, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25746038
15.
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.
J Clin Oncol
; 31(7): 860-7, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23341518
16.
Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.
J Clin Oncol
; 31(23): 2870-8, 2013 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23857972
17.
A potential anatomic cause of mandibular osteonecrosis in patients receiving bisphosphonate treatment.
Mayo Clin Proc
; 82(1): 134; author reply 134-5, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17285795
18.
miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro.
Clin Cancer Res
; 18(24): 6702-13, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23060431
19.
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials.
J Clin Oncol
; 29(24): 3224-31, 2011 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21768454
20.
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.
J Clin Oncol
; 29(24): 3214-23, 2011 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21768471